Alzheon Competitors and Similar CompaniesClear all
Alzheon's competitors and similar companies include Syndesi Therapeutics, Vedanta Biosciences, Morphic Therapeutic and CervoMed.
 Alzheon Alzheon is a company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders. |  Vedanta Biosciences Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. |  CervoMed CervoMed (formerly known as Diffusion Pharmaceuticals) is a drug-discovery and development company. | |||
Founding Date | Founding Date 2013 | Founding Date 2018 | Founding Date 2010 | Founding Date 2015 | Founding Date 2001 |
Type | Type Private | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Framingham, US HQ | Locations Ottignies-Louvain-la-Neuve, BE HQ Beerse, BE | Locations Cambridge, US HQ | Locations Waltham, US HQ | Locations Charlottesville, US HQ |
Employees | Employees 3310% increase | Employees 109% decrease | Employees 1381% increase | Employees 76 | Employees 10 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.9 b | Valuation ($) 111.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $521k (FY, 2023) | Revenue (est.) $4m (FY, 2025) |
Net income | Net income ($5.5m) (FY, 2017) | Net income N/A | Net income N/A | Net income ($152.1m) (FY, 2023) | Net income ($27m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 15.8m (almost 9 years ago) | Latest funding round N/A | Latest funding round $ 68m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 37.1m | Total funding raised $ 21.1m | Total funding raised $ 185.5m | Total funding raised $ 131.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Syndesi Therapeutics
HQ
Ottignies-Louvain-la-Neuve, BE
Syndesi Therapeutics is a biotech company developing molecules.
View companyVedanta Biosciences
HQ
Cambridge, US
Employees
138↑ 1% increase
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
View company
Morphic Therapeutic
HQ
Waltham, US
Employees
76
Morphic Therapeutic operates as a biotechnology company.
View companyCervoMed
HQ
Charlottesville, US
Employees
10
CervoMed (formerly known as Diffusion Pharmaceuticals) is a drug-discovery and development company.
View company